For those who have been infected with the corona virus, a single dose of a vaccine designed to protect them from the potentially contagious code 19 may be sufficient.
This is according to the preliminary results of a medical study conducted in the United States.
The study by the Ashkenazi School of Medicine in Mount Sinai found that people were more likely to report side effects after using a second dose of the vaccine.
However, people with COD 19 have a slightly different reaction, not only after the first dose of the vaccine, but also because of the side effects, including fatigue, headache, chills, fever, muscle and joint pain. I also have a higher rate of antibodies than those who are immune.
The results of this study have not yet been published in any medical journal but have been published online.
The study found that people with COD 19 had at least 10 times higher levels of antibodies against the disease after the first dose of the vaccine than those with the disease.
The researchers said that this means that a single dose of vaccine may be sufficient to provide adequate protection to people with the disease in the past, while also helping them to avoid these harmful effects. Which appear after the second dose.
This study reinforces the findings of another preliminary study, which found that medical workers who have been exposed to COD 19 in the past had higher levels of antibodies after the first dose of the vaccine than others. Number viewed.
“We think a single dose of the vaccine is enough for such people, it will also help them avoid unnecessary discomfort they may experience after the second dose,” said Floren Kramer, a virologist at the Ashkenazi School of Medicine. , While a meal will also be saved.
The second study involved 59 medical workers, 42 of whom had previously suffered from COD (with or without symptoms).
The researchers did not analyze the side effects of the vaccine, but found that people who had had the disease in the past had higher levels of antibodies than the first dose of the vaccine to protect against the disease. Occurs after the second dose in people with
The researchers said that those who have been exposed to the code should be dropped from the priority list of vaccine supplies as long as the supply is limited.
However, a limited number of people were included in both, which is why many scientists say it is too early to form a definitive opinion at this time.